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a  b  s  t  r  a  c  t
The  development  of  ectopic  neural  discharge  at  a  site of peripheral  nerve  injury  is  thought  to  contribute
to  the  initiation  of  sensory  disturbances  and  pain.  We  have  previously  shown  that  this  discharge  can  be
initiated  or  increased  by  the neuropeptide  calcitonin  gene-related  peptide  (CGRP).  We  have  now  stud-
ied  a  potential  therapeutic  approach  to reducing  the  discharge  by  evaluating  the effect  of a systemically
administered  monoclonal  antibody  to  CGRP  on  injury-induced  activity  in  the  lingual  nerve.  In 16 anaes-
thetised  adult  ferrets  the  left  lingual  nerve  was  sectioned.  One  day  after  the  injury,  the  animals  received a
subcutaneous  injection  of  either  a  monoclonal  antibody  to  CGRP  or a vehicle  control.  Three  days  after  the
injury,  under  a  second  anaesthetic,  single-unit  electrophysiological  recordings  were  made  from  central
to  the  injury  site  (469  and  391  units  were  analysed  in  antibody  and  vehicle  groups,  respectively),  and
the  proportion  of units  that  were  spontaneously  active  was  determined.  In the  vehicle-treated  animals
6.4  ±  2.7  [SEM]%  of  the  units  were  spontaneously  active,  with  conduction  velocities  of 8.8–40.8  m/s  andeuropathic pain discharge  frequencies  of  0.03–2.7  Hz. In  the  monoclonal  antibody-treated  animals  5.7  ±  2.0%  of  the  units
were  spontaneously  active,  with  conduction  velocities  of  13.9–38.8  m/s  and  discharge  frequencies  of
0.07–1.8  Hz.  There  was  no  signiﬁcant  difference  between  these  two  groups  (for  spontaneous  activity  and
conduction  velocity:  p > 0.05,  Student’s  t-test;  for discharge  frequency:  p > 0.05,  Mann–Whitney  test),  sug-
gesting  that  the  spontaneous  activity  initiated  by a  nerve  injury  cannot  be modulated  by  administration
of  a  monoclonal  antibody  to  CGRP.. Introduction
Shortly after sectioning a peripheral nerve, the damaged axons
tart to behave abnormally [8,14]. Some axons discharge action
otentials spontaneously in the absence of any stimulus, and others
espond to gentle mechanical distortion of the injury site. The dis-
harge is thought to result from alterations in the expression of ion
hannels and other regulators of neuronal excitability within the
amaged axons. This centrally directed ectopic activity is thought
o contribute to the pain and dysaesthesia experienced by some
atients, and reduction of the discharge may  provide the basis for
uture pharmacological treatment [7].
We have previously studied injury-induced ectopic activity
n the lingual nerve, a branch of the trigeminal nerve that is
usceptible to iatrogenic damage during routine surgical pro-
edures, such as the removal of lower third molars [12]. We
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showed that 3 days after sectioning the nerve in anaesthetised
adult ferrets, up to 36% of the axons became spontaneously active
and up to 35% were sensitive to mechanical stimulation [15].
In parallel immunocytochemical studies, we found an accumu-
lation of neuropeptides at the injury site, and the maximum
accumulation of peptides coincided with the periods of great-
est spontaneous activity [2]. One of the neuropeptides present
was calcitonin gene-related peptide (CGRP) and, in view of its
known role in neural transmission and neuromodulation [13],
we hypothesised that it might modify the abnormal discharge
after nerve injury. This possibility was conﬁrmed in studies on
another branch of the trigeminal nerve, the inferior alveolar
nerve, in which topical or close-arterial application of CGRP or
a CGRP antagonist was  found to initiate or modulate the dis-
charge from some damaged axons [9]. Here we have pursued
a novel approach to modifying the action of CGRP on damaged
Open access under CC BY license.axons, using systemic administration of a monoclonal antibody
to CGRP two days prior to electrophysiological recordings; we
have also reverted to the lingual nerve as our experimental
model.








































(ig. 1. A diagrammatic representation of the recording arrangement. ‘S’ denotes th
ite  and the junction with the chorda tympani.
. Methods
Sixteen adult female ferrets aged 5–8 months and weighing
.7–1.1 kg were used in this investigation, and all procedures were
ndertaken in accordance with the UK Animals (Scientiﬁc Proce-
ures) Act, 1986. Under anaesthesia (ketamine, 25 mg/kg; xylazine,
 mg/kg; i.m.), an incision was made in the left submandibular
egion and the mylohyoid muscle split to expose the left lingual
erve lying on the pharyngeal constrictor muscle. The nerve was
ectioned using micro-scissors and left in alignment. The inci-
ion was closed and a single dose of antibiotic was administered
ampicillin 22.5 mg/kg, i.m.; Duphacillin, Fort Dodge, UK). One
ay later, the animals received a subcutaneous injection of either
 monoclonal antibody to CGRP (Sigma–Aldrich, USA; 2 mg/ml
dministered at 1 ml/kg, 8 animals) or the phosphate-buffered
aline (PBS) vehicle (8 animals). The antibody had previously been
ialysed in PBS using Slide-A-Lyzer dialysis cassettes (Pierce, Rock-
ord, IL, USA) to remove the 15 mM sodium azide.
On the third day post-injury, the animals were re-anaesthetised
ith sodium pentobarbitone (induction 40 mg/kg i.p.; maintenance
.5–10 mg/kg i.v. as required), the trachea was cannulated, the ECG
ecorded, and body temperature was maintained at 38 ± 0.5 ◦C with
 thermostatic heating blanket. The animal was  prepared for the
lectrophysiological recordings as previously described [15], and
he investigator was kept blind to the experimental group. In brief,
he lingual nerve was exposed at the injury site and central to its
unction with the chorda tympani, by removal of the ramus and
art of the body of the mandible. It was then covered in warm liquid
arafﬁn in a pool created from the surrounding skin. After divid-
ng the epineurium with a razor chip, ﬁne ﬁlaments were dissected
rom the nerve and placed directly on platinum wire electrodes
0.15 mm diameter). To avoid centrally mediated spontaneous dis-
harge, the nerve was sectioned centrally. A pair of stimulating
lectrodes was placed across the nerve approximately 3 mm  cen-
ral to the injury site, and isolated from the underlying muscle
ith a small piece of paraﬁlm (Paraﬁlm ‘M’, American National Can,
SA). The experimental and recording arrangements are illustrated
iagrammatically in Fig. 1.
For each ﬁlament, the following characteristics were deter-
ined:a) The number of units in the ﬁlament
This was determined on an oscilloscope by assessing recruit-
ment of individual units in response to steadily increasing of stimulation and ‘R’ denotes the site of the recordings, central to both the injury
electrical stimuli of 0.1 ms  duration and up to 10 V applied to
the electrodes near the injury site.
b) The number of units that were spontaneously active
After initial assessment on the oscilloscope, any activity was
recorded on disk and analysed using a 1401 Plus interface and
Spike 2 for Windows software (Cambridge Electronic Design
Ltd., Cambridge, UK). This software allows spontaneously active
units to be identiﬁed based on their action potential shape and
amplitude. The discharge frequency of each unit was  deter-
mined and categorised as regular or irregular. The proportion
of spontaneously active units in antibody- and vehicle-treated
groups was compared using an unpaired Student’s t-test. The
discharge frequency of spontaneously active units in the two
groups was  compared using an unpaired Mann–Whitney test.
In both cases signiﬁcance levels were set at p < 0.05.
(c) The conduction velocity of each unit
This was calculated for each unit from the latency of the
response to the electrical stimuli applied at the injury site. The
conduction velocity of spontaneously active units in the two
groups was compared using Student’s t-test.
To assay antibody levels, approximately 1 ml  of blood was col-
lected from a superﬁcial vein in the hind limb at the end of each
experiment, placed into EDTA-coated tubes, centrifuged at 4 ◦C for
5 min  at 5000 rpm, and the plasma stored at −80 ◦C. Analysis to
quantify antibody levels was  undertaken using an enzyme-linked
immunosorbant assay (ELISA). ELISA plates were coated overnight
(4 ◦C) with anti-mouse IgG1 (BD Biosciences, San Jose, USA) in car-
bonate coating buffer (pH 9.6), washed three times with wash
buffer (0.02 M Tris pH 7.4, 0.15 M NaCl, 0.1% Tween-20) and blocked
for 1 h at room temperature with 1% bovine serum albumin (BSA)
in wash buffer. Plates were washed again prior to the addition
of plasma samples in duplicate. The samples were tested at 100,
400, 1600 and 6400 times dilutions. The captured antibody was
detected using an anti-mouse kappa-HRP (BD Biosciences, San
Jose, USA) and the assay was  developed using o-phenylenediamine
(Sigma–Aldrich, St. Louis, USA) for 6 min  and the reaction was
stopped by adding 1 N HCl. A standard curve of the puriﬁed anti-
CGRP antibody was  used to calculate the plasma concentration.
3. ResultsNo apparent adverse reactions were observed during the mon-
itoring period post-vehicle or antibody administration. A total of
469 units in 145 ﬁlaments were analysed electrophysiologically in
148 K.E. Bowler et al. / Neuroscience Letters 505 (2011) 146– 149





























Fig. 4. Box and whisker plots showing the mean and median discharge frequencies
recorded in spontaneously active units from vehicle and antibody treated animals.
tions ranging from 4.82 to 9.02 g/ml (mean 6.31 ± 0.76 g/ml) inig. 2. Spontaneous activity (SA) recorded in a unit dissected from the lingual nerve
oftware, and four spontaneously active units are shown.
he antibody group (mean 58 units per animal, range 33–95) and
 total of 391 units in 143 ﬁlaments were analysed in the vehi-
le group (mean 48 units per animal, range 18–83). Spontaneously
ctive units were recorded in both treatment groups and examples
an be seen in Fig. 2. Fig. 3 shows the mean percentage of sponta-
eously active units in vehicle and antibody treated animals. In the
ntibody group a total of 28 units were spontaneously active (range
–9 units per animal) whilst in the vehicle group, 21 spontaneously
ctive units were recorded (range 0–10 units per animal). There
as no signiﬁcant difference between the two groups in terms of
he proportions of spontaneously active units obtained from each
nimal: the mean proportion of units with spontaneous activity
as 5.7% ± 2.0 [SEM] in the antibody group, and 6.4% ± 2.7 in the
ehicle group (p = 0.82, unpaired Student’s t-test; Fig. 3).
All of the spontaneously active units recorded in both groups
ad an irregular discharge pattern (interspike interval devia-
ion > 50 ms). There was no signiﬁcant difference in discharge rates
etween the treatment groups: discharge rates ranged from 0.07
o 1.82 Hz (median 0.24 Hz) for animals in the antibody group, and
rom 0.03 to 2.7 Hz (median 0.27 Hz) for animals in the vehicle
roup (p > 0.05, unpaired Mann–Whitney test, Fig. 4).
There was no signiﬁcant difference in conduction velocities of
he spontaneously active units between the two groups. Conduc-
ion velocity ranged from 13.9 to 38.7 m/s  (mean 25.9 ± 2.0 m/s)
n the antibody-treated animals and from 8.8 to 40.8 m/s  (mean
4.5 ± 2.05 m/s) for the vehicle-treated animals (p = 0.63, unpaired
-test, Fig. 5).
ig. 3. Mean (±SEM) percentage of units in the lingual nerve that were sponta-
eously active 3 days post injury.The  dotted line represents the mean discharge frequency and the solid line repre-
sents the median.
The CGRP antibody assays revealed average plasma concentra-the treated animals. No antibody was  detected in animals that had
received the vehicle.
Fig. 5. Box and whisker plots showing the mean and median conduction velocity
recorded for the spontaneously active units found in each treatment group. The
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. Discussion
In common with our previous studies on the response of dam-
ged trigeminal nerves to injury [4,15],  we found spontaneously
ischarging units in most animals three days after nerve section.
ll of these units had irregular discharge patterns, low discharge
requencies and included myelinated ﬁbres across a broad range of
onduction velocities. In the present experiments, we  have shown
hat systemic administration of a monoclonal antibody to CGRP
oes not reduce the proportion of lingual nerve axons that develop
n ectopic discharge following injury, nor does it change the dis-
harge frequency. Furthermore, the range of conduction velocities
f the spontaneously discharging axons was unaltered, suggesting
hat there was no change in the ﬁbre population that was affected.
In the present study, we were not able to assess levels of sponta-
eous activity in all ﬁbre types as we were not able to discriminate
ingle unmyelinated ﬁbres. Also, for technical reasons, it was not
ossible to establish the effects of the antibody on mechanical sen-
itivity. Thus, it is possible that the antibody may  have had some
ffect on these parameters.
The use of a systemically administered antibody for pain
odulation is a novel approach and we have previously shown
hat the same antibody reduces central neuronal activation in a
rigeminal inﬂammatory pain model [5,6]. In those studies, Fos
xpression in the trigeminal nucleus was quantiﬁed in response
o stimulation of the inﬂamed ferret tooth pulp, and was  sig-
iﬁcantly lower after antibody administration. The dose and
ime course used, and plasma concentrations achieved were
ery similar to those of the present investigation. This dose of
ntibody has also been shown by Eli Lilly to inhibit dural plasma
xtravasation induced by stimulation of the trigeminal ganglion
http://www.wipo.int/patentscope/search/en/WO2007076336).
hus, it seems likely that the plasma concentrations in the present
tudy would have been sufﬁcient to sequester CGRP at the injury
ite. Taken together these data suggest that this approach may
e effective for inﬂammatory but not neuropathic pain. Further
tudies utilising appropriate behavioural models are necessary to
stablish this.
This result was surprising as evidence for a potential role for
GRP in the aetiology of injury-induced spontaneous discharge is
ompelling. In addition to the known accumulation of CGRP in
he damaged axons [2,3] and effects of CGRP and CGRP antago-
ists when applied locally [9],  there is also clinical evidence that
amaged lingual nerves have higher levels of CGRP in patients suf-
ering from pain than in patients without pain [11]. The mechanism
y which the CGRP might exert an inﬂuence is not clear and it
ould act indirectly rather than directly on the neuronal tissues.
ne such mechanism could be via the vasculature as CGRP is a
otent vasodilator, and Zochodne et al. [17] have demonstrated a
ocal reduction in blood ﬂow when CGRP antagonist was applied
opically to a sciatic nerve neuroma. Another possibility is that
GRP could affect the neuronal discharge through modulation of
mmunological and inﬂammatory responses [10], which are also
hought to play a role in neuropathic pain. However, the data from
he current study indicate that blocking the effect of CGRP alone
oes not affect the level of spontaneous discharge.
Alternative methods for modiﬁcation of spontaneous discharge
rom injured axons must therefore be sought. Carbamazepine,
 membrane stabilising drug, and SB-750364, a TRPV1 receptor
ntagonist, have both been shown to reduce spontaneous discharge
rom some damaged lingual nerve axons, whilst others are not
ffected [1,16].  Such drugs might therefore be expected to give par-
ial relief of symptoms, and use of carbamazepine in patients with
[
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dysaesthesia conﬁrms this effect in some individuals [12]. More
universally effective treatments are required.
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